| Prev Close | 72.60 |
| Day Low/High | 72.07 / 73.30 |
| 52 Wk Low/High | 69.72 / 89.70 |
Baxter International Inc. (BAX)
73.23
NYSE
| Exchange | NYSE |
| Shares Outstanding | 503.53B |
| Market Cap | 36.56B |
| P/E Ratio | 44.92 |
| Div & Yield | N.A. (N.A) |
Latest News
Biden Bits, Vaccine Vanguard, Unmasking Folly, Minerd Musings, Ives Inklings
Among other things, the president works to align Democratic senators to support his massive Covid relief bill.
Here's How I'm Going to Fix My Position in Merck
This is my fifth worst performing position in a book that contains 62 open positions.
Where Health Meets Tech: 7 Testing and Diagnostics Stocks to Know
Experts pick their favorite long-term investments in medical diagnostics, testing and laboratory services.
Trading Volumes Rising, GDP Forecasts, Earnings and Trading Thoughts
Market leadership may be lacking on Thursday despite rising trading volumes, plus an update on Apple, Microsoft, Mastercard, Amazon and Gilead.
I'm Dusting Off My Old Playbook for Bonds Right Now
After a strong day for fixed-income markets, let's learn from 2008 how to play this volatility.
Jim Cramer: More News Will Move More Stocks
What if a stock is being propelled by actual events or changes?
Baxter International's Prognosis Looks Poor, Consider Selling
BAX saw shares plunge 10% last week on news of accounting irregularities and the charts appear bearish.
Baxter International Breaks Its February/April Lows: Now What?
BAX is now in a weak technical position.
Jim Cramer: Even Safe-Haven Big-Cap Drug Stocks Are Now Broken
Once the safest stocks in the book, the big-cap drug companies are now toxic.
Jim Cramer: These Are the Stocks to Buy on Canada Deal and the 4th Quarter
Straying from these names could land you in quicksand as the 4th quarter begins.
Jim Cramer: Here's Why the Market Rally Has Staying Power
For most of this year the market has been led by growth stocks.
The Dip in Baxter International Should Soon Be a Buying Opportunity
BAX declined recently to break the rising 50-day moving average line.
Medical Device Stocks Could Be Gearing Up to Be Market Leaders
When chartists look for the next market leaders they often go to stocks that have held up the best during corrections.
Jim Cramer: When Rates Decline, 96% of the S&P 500 Benefits
When rates decline, most of the S&P 500 benefits, according to TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer.
Jim Cramer: Stocks That Do Well In a Declining Rate Environment Are Back
The crash of oil will only accelerate the move.
Why Value Investor Benjamin Graham Remains Relevant Today
I still also use Graham-inspired stock screens, including one based on his 'stocks for the defensive investor' methodology.
Cramer: The 12 Strongest Sectors Going Into Earnings
It is incredibly healthy to see so many stocks so strong, from so many sectors.
These Stocks Are Ready to Reverse Course
This week's bullish and bearish reversal patterns.
Cramer: There Are Powerful Themes in Several Bull Markets
It's a wonder to me how split this market really is.
These 'Rocket Stocks' Look Ready for Blastoff
These four stocks are showing short-term gain catalysts and longer-term growth potential.
Cramer: The Best Performers Show No Signs of Letting Up
Their overseas business has been carrying them.
Cramer: We Have Nothing to Distinguish the Stocks Right Now
We know that we are in the era when index managers are ascendant.
Baxter's Chart Is Still Bullish
Our price objective is $68.
Retail Stocks Don't Make Good Value Plays
Five names to consider from my 'stocks for the defensive investor' screen.
Baxter International Maintains Its Long-Running Uptrend
Recent upside breakout refreshes bull trend.
Cramer: Money's Being Thrown at Almost Everything in the Market
There are nearly too many surging sectors to count.
Baxter Buys Claris Injectables for $625 Million
Baxter buys generic drug maker Claris Injectables in a deal that will be accretive to earnings.
